Document Detail

IGFBP2 as an Immunohistochemical Marker for Prostatic Adenocarcinoma.
MedLine Citation:
PMID:  21304397     Owner:  NLM     Status:  Publisher    
AIM: The aim of the study was to evaluate the immunohistochemical expression of insulin-like growth factor binding protein 2 (IGFBP2) in normal epithelium, high-grade prostatic intraepithelial neoplasia (HG-PIN), and prostatic adenocarcinoma (PAc), in patients hormonally untreated and in those having undergone complete androgen ablation. MATERIALS AND METHODS: IGFBP2 expression was evaluated in PAc, HG-PIN, and normal-appearing epithelium in 40 radical prostatectomies from hormonally untreated patients and 10 radical prostatectomies from patients under complete androgen ablation before surgery. The study also included the initial biopsies of such patients, and an additional 10 simple prostatectomies from patients with bladder outlet obstruction. Statistics included receiver-operator characteristic curves, the Wilcoxon test, and the Spearman test. Results were compared with α-methylacyl-CoA racemase. RESULTS: The principal findings were: (1) IGFBP2 was not expressed in normal ducts and acini of the transition and peripheral zones; (2) IGFBP2 was expressed in the cytoplasm of untreated PAc and, to a lesser extent, in HG-PIN; (3) it was also expressed in PAc and HG-PIN after complete androgen ablation, but to a lesser extent than in the untreated neoplasms; (4) α-methylacyl-CoA racemase was expressed both in PAc and HG-PIN, the level being similar in both lesions and lower in the specimens from the patients having undergone androgen ablation. CONCLUSIONS: Results obtained show that IGFBP2 is expressed in invasive PAc, whereas its expression in HG-PIN is low. These findings can be helpful in the correct diagnosis of PAc both in biopsies and in surgical specimens, mainly in untreated patients.
Andrea Ambrosini-Spaltro; Anna Farnedi; Rodolfo Montironi; Maria P Foschini
Related Documents :
19339417 - Erythropoietin therapy and left ventricular mass index in ckd and esrd patients: a meta...
9203047 - Plasma erythropoietin level and iron reserves in haemodialysis patients with and withou...
10543327 - Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis ...
18673207 - Therapeutic strategy of erythropoietin in neurological disorders.
451077 - Velopharyngeal function following maxillary advancement.
24941927 - Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-5
Journal Detail:
Title:  Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry     Volume:  -     ISSN:  1533-4058     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888796     Medline TA:  Appl Immunohistochem Mol Morphol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
*Section of Anatomic Pathology, Department of Oncology and Hematology, University of Bologna, Bellaria Hospital, Bologna †Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Laparoscopic deroofing of nonparasitic liver cysts with or without greater omentum flap.
Next Document:  Establishment and Large-scale Expansion of Minimally cultured "Young" Tumor Infiltrating Lymphocytes...